Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;19(9):567-76.
doi: 10.1016/j.jnutbio.2007.10.001. Epub 2008 Apr 21.

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

Affiliations
Review

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

Christopher L Gentile et al. J Nutr Biochem. 2008 Sep.

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as a serious obesity-related disorder. NAFLD encompasses a wide spectrum of hepatic derangements ranging from a surfeit of fat in the liver (steatosis) to lipid surplus accompanied by fibrosis and cellular death (nonalcoholic steatohepatitis or NASH). The most widely accepted model to explain the progression from simple NAFLD to NASH is the "two-hit hypothesis," wherein fat over accumulation per se is not sufficient to induce the progression to statohepatitis, but renders the liver more susceptible to "second hits" that, once imposed upon the steatotic liver, cause further aberrations that culminate in the development of NASH. However, in light of recent data from our laboratory and elsewhere, we propose that an increased ratio of saturated-to-unsaturated fatty acids delivered to or stored within the liver may, in part, mediate the progression from simple steatosis to NASH. The molecular mechanisms that mediate the effect of saturated fatty acids are unclear, although proinflammatory cytokines, reactive oxygen species, and endoplasmic reticulum stress may all play a role. Collectively, these data suggest that saturated fatty acids may represent an intrinsic second hit to the liver that hastens the development of NASH.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Caspase activity and DNA fragmentation in H4IIE liver cells. A) Caspase-3 activity and DNA fragmentation were measure in liver cells following 6 or 16 hours of exposure to a control media (LG) or a control media supplemented with thapsigargin (Th, positive control), oleate at 500 μM (O500), palmitate at 500 μM (P500), linoleate at 500 μM (L500), or stearate at 500 μM (S500). B) DNA fragmentation was measured in liver cells following 16 hours of exposure to control media (LG) or control media supplemented with the noted concentrations of fatty acids. *, significantly different from LG and O500 or LG and L500 (p<0.05) [34].
Figure 2
Figure 2
Liver triglycerides, saturated fatty acid composition, caspase-3 activity and liver enzymes in dietary models of hepatic steatosis. Rats were fed a high starch (STD), high sucrose (HSD), high polyunsaturated fat (HPUF) or high saturated fat (HSAT) diet for 4 or 24 weeks. A) Liver triglyceride (TG) concentration and the sum of saturated fatty acids in triglycerides (SatTG) and microsomal membranes (SatMem). B) Liver caspase-3 activity and plasma concentrations of alanine aminotransferase (AAT) and aspartate aminotransferase (AST). *, significantly different from STD and HPUF (p<0.05) [33].
Figure 3
Figure 3
A) Schematic diagram depicting major components of the unfolded protein response as described in text. B) Schematic diagram depicting (bold and italics) the components of the UPR that are known to be activated in response to long chain saturated fatty acids.
Figure 4
Figure 4
Schematic diagram depicting disease progression in NAFLD and hypothesized second hits.

Similar articles

Cited by

References

    1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200. - PubMed
    1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2003;289:76–79. - PubMed
    1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529. - PubMed
    1. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Reviews. 2004;5:27–42. - PubMed
    1. Clark JM, Diehl A. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA. 2003;289:3000–3004. - PubMed

Publication types

LinkOut - more resources